Thyrocare Technologies

THYROCARE

₹ 1,147.12

- ₹ 5.60

0.49%

Healthcare

₹ 0.00

(%)1D

Updated: 15 Jul 2025, 03:31:28 pm IST

Stock Score

Open Price

₹ 1,153.37

Prev. Close

₹ 1,152.72

₹ 1,091.81

Day Low

₹ 1,161.87

Day High

₹ 619.17

52 Week Low

₹ 1,169.12

52 Week High

Quick Bite

Price To Earnings Ratio 67.00	Sector PE 39.17
PB Ratio 11.21	Sector PB 7.64
EPS 17.12	Dividend Yield 3.09
Today's Volume 156.367 K	5 Day Avg. Volume 154.876 K
PEG Ratio 2.43	Market Cap. ₹ 5,750.00 Cr.

About Thyrocare Technologies

Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It conducts an array of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include diagnostic testing services, imaging services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radiopharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It is also focused on offering pathological services.

Thyrocare Technologies Share Price

Thyrocare Technologies Limited is an Indian healthcare provider. The company has a Centralized Processing Laboratory (CPL) in Mumbai, India for esoteric testing and a regional processing laboratory in major cities in India and the rest of Asia. The company offers technologies such as chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), high-performance liquid chromatography (HPLC), capillary electrophoresis (CE), ion-selective electrodes (ISE), fluorescent flow cytometry, nephelometry, liquid photometry, chromatography mass spectrometry (LC-MS). , inductively coupled plasma mass spectrometry (ICP-MS) and cytogenetics. The company offers various tests such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. It also offers thyroxine (T4), triiodothyronine (T3), thyroid stimulating hormone and complete vitamin profile tests.

Thyrocare Technologies FAQs

How to Buy Thyrocare Technologies Share?

To purchase Thyrocare Technologies shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Thyrocare Technologies (ticker symbol: THYROCARE) on the trading platform provided by your broker and purchase the shares.

What's Thyrocare Technologies share price today?

The stock price of Thyrocare Technologies as of 15 Jul 2025 is ₹1,147.12

What is the Market Cap of Thyrocare Technologies?

Market capitalisation represents the total market value of a company's outstanding shares. As of 15 Jul 2025, Thyrocare Technologies (ticker symbol: THYROCARE) has a market capitalisation of approximately ₹57,50,00,00,000.00

What is the PE and PB ratio of Thyrocare Technologies?

Thyrocare Technologies Ltd's price-to-book ratio as of 15 Jul 2025 is 11.21, reflecting the market's valuation compared to its asset value. As of 15 Jul 2025, the trailing twelve months P/E (price-to-earnings) ratio is 67, indicating the market values the company at around ₹67.00 for every ₹1 of earnings

What is the 52 Week High and Low of Thyrocare Technologies Share?

Thyrocare Technologies Ltd (THYROCARE) hit its 52-week high at ₹1,169.12, and its 52-week low at ₹619.17.

Begin your investment journey today

View All Global Indices